How Many Calories Should You Eat on Mounjaro?
In this article
Most people on Mounjaro (tirzepatide) do not need to count calories, because the medicine does the restricting: its product information says it reduces energy intake by increasing fullness and decreasing hunger and food cravings, and the number that matters is the floor, not the ceiling.1 The trials asked participants only to follow "a reduced calorie diet and increased physical activity"; the semaglutide trials, which spelt it out, used a 500 kcal a day deficit with 150 minutes of activity a week.1, 2 Against the NHS averages of 2,000 kcal a day for a woman and 2,500 for a man, that is roughly 1,500 to 2,000 kcal, a moderate cut.3 The NHS puts anything under 1,200 kcal in the category of a very low calorie diet, to be followed with a dietitian's support and "usually only recommended if your weight is affecting other health conditions".4
Evidence at a glance
- Appetite: in a manufacturer-funded trial of 114 adults with overweight or obesity, tirzepatide cut what people ate at a test lunch by about 525 kcal against placebo after three weeks, with less hunger and fewer cravings.5
- The trial deficit: 500 kcal a day below needs, plus 150 minutes of activity a week, in the semaglutide trials; "reduced calorie diet" in the tirzepatide trials.1, 2
- Lean tissue: about 25% of weight lost in the 160-person tirzepatide substudy, and across 22 trials of 2,258 adults on GLP-1 medicines.6, 7
- Not tested: no trial has compared calorie levels against outcomes in people taking tirzepatide.
Sources checked on 5 November 2026.
Why calorie counting usually backfires on Mounjaro
Dieting without medicine means fighting appetite with willpower, and counting is one way to do it. Tirzepatide removes most of the fight: the product information says it increases satiety and decreases hunger and food cravings, and in a manufacturer-funded trial of 114 adults with overweight or obesity, tirzepatide cut what people ate at a test lunch by about 525 kcal against placebo after three weeks.1, 5 Counting on top of that tends to push people lower than they should be. The weight-loss trials show that when calories are cut hard, the share of fat-free mass lost rises unless protein is kept up, and the body's defence of its old weight strengthens: a review of adaptive thermogenesis describes the fall in energy expenditure and the hormonal responses that oppose a reduced body weight and drive the regain seen in more than 80% of dieters.8, 9 This is the calories chapter of living well on Mounjaro; why your weight loss has stalled takes the under-eating cause further.
So how many calories should you eat?
In numbers:
- The trial pattern: about 500 kcal a day below what maintains your weight, which the semaglutide trials specified and the tirzepatide trials described as a reduced-calorie diet.1, 2 For most adults that is roughly 1,500 to 2,000 kcal a day against the NHS averages of 2,000 and 2,500.3 That produced the trial results; nobody needed 800.
- The NHS floor: under 1,200 kcal a day is a very low calorie diet in NHS terms, supervised by a dietitian and usually reserved for people whose weight is affecting other conditions.4 Below it, protein, fibre and micronutrients are hard to get from food: a 2026 review of 480,825 adults on GLP-1 medicines found more than 60% below their requirements for calcium and iron.10
- Higher if you are tall, heavy, very active or breastfeeding; a dietitian sets that figure, not an app.
One practical check: three meals and a snack, each with a protein source, every day, portions set by comfort. Hit that and you are above the floor.
Is 1,000 calories a day enough on Mounjaro?
Not as a pattern. A day or two happens, especially after a dose increase, when the product information says nausea and the other gut effects peak.1 Weeks of it are a problem for three reasons. Protein: at 1,000 kcal, 1.2 to 1.6 g per kilogram of body weight, the range the weight-loss research supports, takes most of the plate.11 Muscle: across 24 weight-loss trials, higher protein kept 0.43 kg more fat-free mass and a higher resting energy expenditure than standard protein at the same calories, and the tirzepatide substudy lost a quarter of its weight as lean mass even at trial intakes.6, 8 Nutrients: the deficiencies the 2026 review recorded, vitamin D in 7.5% at six months and 13.6% at twelve, track with how little is eaten.10 If you are regularly under 1,000, the product information's own route is the prescriber's: with significant gut symptoms a dose increase can be delayed or the previous dose resumed.1
Signs you are eating too little
Under-eating on Mounjaro does not feel like hunger, which makes it easy to miss. It feels like the medicine's side effects. Dehydration from the gut effects, which the product information warns about, shows up as feeling tired, headache, feeling dizzy or light-headed and dark urine, all on the NHS list.1, 9 Hair shedding three to four months in is telogen effluvium, the diffuse shedding that follows sudden weight loss, and hair loss was reported by 4.9% of people on tirzepatide against 1.0% on placebo in the weight-management trials.1, 12, 14 Feeling cold, poor sleep, irritability and a stall on the scales complete the picture; the tell is that eating more fixes it within days. Why am I so tired on Mounjaro and why do I feel cold on Mounjaro go into two of these, and does Mounjaro cause muscle loss covers the third.
How to eat enough when you have no appetite
Schedule it. Hunger will not remind you, so the clock has to: something with protein within an hour of waking, then every three to four hours.
Protein first. Eggs, yoghurt, cottage cheese, fish, chicken, tofu, lentils, a shake if you cannot face food; 25 to 30 g a meal is the practical portion.11 How much protein you need has the figures for your weight.
Dense, not bulky. When you can only manage a small volume: full-fat yoghurt, nut butter on toast, olive oil on vegetables, cheese, whole milk in porridge, a handful of nuts; soups and smoothies when solid food is unappealing.
Fluid between meals, so water does not take the space food needs, and enough of it that your urine is pale, the NHS yardstick.9
Treat a run of sub-1,000 days as a prescriber conversation, not a win. The usual answer is to hold the dose until eating recovers, and that is their call.1
What about tracking?
If you like tracking, track protein and fibre rather than calories: 1.2 to 1.6 g of protein per kilogram and the NHS 30 g of fibre a day are targets to reach, and reaching them keeps you above the floor.11, 13 If you want to track calories for a week to see where you land, do it as a check and stop once you know. People with a history of disordered eating should not track at all, and should tell their prescriber.
What we don't know
- The ideal intake on tirzepatide: the trials prescribed a diet, and nobody has compared intakes against outcomes.1
- How far resting metabolism falls with very low intake on these medicines, and how much protein and training offset it.8, 9
- Whether under-eating early predicts regain later: plausible from the weight-maintenance research, unstudied here.9
Frequently asked questions
How many calories should I eat a day on Mounjaro?
About 500 kcal below what maintains your weight, which for most adults is roughly 1,500 to 2,000 kcal, with protein at every meal; the NHS treats anything under 1,200 as a very low calorie diet for a dietitian to supervise.2, 3, 4
Is 800 calories a day enough on Mounjaro?
No, not without a dietitian. The NHS classes 800 kcal as a very low calorie diet reserved for people whose weight is affecting other conditions; below about 1,200 it is hard to get enough protein and micronutrients, more of the weight lost is lean mass, and tiredness, hair shedding and stalls follow.4, 8, 10
Do you need to count calories on Mounjaro?
Usually not. The medicine creates the deficit by increasing fullness and reducing hunger; count protein and fibre if you want to track something, and use calories only as a short check.1
Why am I not losing weight on 1,000 calories on Mounjaro?
Very low intakes lower energy expenditure and cost muscle, and the body defends its old weight harder the further you cut.8, 9 Eating to the trial pattern with enough protein, and asking your prescriber about the dose, is the route the evidence supports.
Sources
- Tirzepatide Summary of Product Characteristics, sections 4.2 (dose escalation), 4.4 (dehydration), 4.8 (undesirable effects, hair loss 4.9% against 1.0%) and 5.1 (appetite, trial diet), electronic medicines compendium, date of revision of the text 29 August 2026. medicines.org.uk.
- Semaglutide (Wegovy) Summary of Product Characteristics, section 5.1 (STEP 1, 2 and 4: "reduced calorie diet (500 kcal/day deficit) and increased physical activity (150 min/week)"), electronic medicines compendium, date of revision of the text 09/2026. medicines.org.uk.
- NHS. Understanding calories. Reviewed 17 April 2023 (review overdue). nhs.uk.
- NHS. Obesity: treatment. Reviewed 29 April 2026. nhs.uk.
- Martin CK, et al. Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial. Nature Medicine, 2025. Randomised phase 1 trial, 114 adults, 6 weeks; manufacturer-funded, eleven of nineteen authors its employees. PubMed 40555748.
- Look M, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study. Diabetes, Obesity and Metabolism, 2025. Scan substudy of a randomised trial, 160 adults, 72 weeks; manufacturer-funded, six of eight authors employees. PubMed 39996356.
- Karakasis P, et al. Effect of GLP-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis. Metabolism, 2025. Pooled analysis, 22 randomised trials, 2,258 adults; authors declare industry fees. PubMed 39719170.
- Wycherley TP, et al. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomised controlled trials. American Journal of Clinical Nutrition, 2012. Pooled analysis, 24 trials, 1,063 adults; non-commercial funding. PubMed 23097268.
- Rosenbaum M, Leibel RL. Adaptive thermogenesis in humans. International Journal of Obesity, 2010. Narrative review; US government funding. PubMed 20935667.
- Urbina J, et al. Micronutrient and nutritional deficiencies associated with GLP-1 receptor agonist therapy: a narrative review. Clinical Obesity, 2026. Narrative review, 6 studies, 480,825 adults, mainly observational; no funding or conflicts listed on PubMed. PubMed 41549912.
- Leidy HJ, et al. The role of protein in weight loss and maintenance. American Journal of Clinical Nutrition, 2015. Narrative review; no funding statement on PubMed. PubMed 25926512.
- Chien Yin GO, et al. Telogen effluvium: a review of the science and current obstacles. Journal of Dermatological Science, 2021. Narrative review; no funding or conflicts listed on PubMed. PubMed 33541773.
- NHS. How to get more fibre into your diet. Reviewed 2 March 2026. nhs.uk.
- Malkud S. Telogen effluvium: a review. Journal of Clinical and Diagnostic Research, 2015. Narrative review; funding not stated on PubMed. PubMed 26500992.
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.
General information, not medical advice. Mounjaro is a prescription medicine: follow your prescriber's instructions, and tell them if you are regularly unable to eat enough.